Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

18 Jul 2007 07:30

Compagnie de Saint-Gobain18 July 2007 press release July 18, 2007 Norandex Acquisition in the United States Saint-Gobain has announced the acquisition of the Norandex group in the UnitedStates from Owens Corning. Norandex has 2,200 employees and delivered sales of$866 million in 2006 split into two activities: building materials distributionand vinyl siding manufacturing. The Norandex merchant brand, which will be integrated within Saint-Gobain'sBuilding Distribution sector, boasts a network of 153 specialized distributionbranches dealing mainly in exterior building products (siding, doors, windows,etc.). Norandex ranks among the top 15 US building merchants in a highlyfragmented market. Norandex has also 3 plants used to manufacture vinyl siding, which aredistributed by its own branches as well as by other independent distributors.The Norandex plants will be consolidated with the existing production facilitiesoperated by the exterior building solutions division of Saint-Gobain'sConstruction Products sector in the United States, and will enable the Group tounlock significant synergies. The completion of this transaction, which values Norandex at an enterprise valueof $343 million (net of cash tax benefits), is subject to the agreement of thecompetition authorities in the United States. In 2006, Saint-Gobain's Building Distribution sector delivered sales of €17.6billion. Its 67,000 employees operate a network of almost 4,000 sales outlets in24 countries. It is currently Europe's leading distributor of building materialsand the world's number one distributor of tiles. Its main brands are Point.P,Jewson, Raab Karcher, Dahl, Lapeyre la maison... and La Plateforme duBatiment. Investor Relations Department Florence Triou-Teixeira Tel.: +33 1 47 62 45 19 Alexandre Etuy Tel.: +33 1 47 62 37 15 Fax : +33 1 47 62 50 62 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jan 20197:06 amRNSNew facility
10th Jan 20195:42 pmRNSDisposal
8th Jan 20197:12 amRNSDisposal
18th Dec 20188:48 amRNSAcquisition
30th Nov 20189:24 amRNSCancellation of shares
26th Nov 20188:21 amRNSLaunching of Transformation Program
23rd Nov 20188:23 amRNSDisposal
25th Oct 20185:02 pmRNS3rd Quarter Results
11th Oct 20183:57 pmRNSFinal Terms
10th Oct 20185:49 pmRNSFinal terms
5th Oct 20187:47 amRNSAcquisition
1st Oct 201810:43 amRNSStabilisation Notice - Compagnie de Saint-Gobain
20th Sep 20185:10 pmRNSAcquisition
20th Sep 20184:57 pmRNSFinal Terms
20th Sep 20184:56 pmRNSFinal Terms
12th Sep 20186:15 pmRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
12th Sep 20185:49 pmRNSIssue of Debt
12th Sep 20188:54 amRNSStabilisation Notice - COMPAGNIE DE SAINT-GOBAIN
24th Aug 20185:21 pmRNSProspectus Supplement
1st Aug 20187:11 amRNSAcquisition
31st Jul 20185:23 pmRNSDivestment
26th Jul 20185:15 pmRNSHalf-year Report
13th Jul 20185:15 pmRNSProspectus
3rd Jul 20189:35 amRNSAcquisition
22nd Jun 20182:34 pmRNSFinal Terms
22nd Jun 20182:33 pmRNSFinal Terms
15th Jun 20188:47 amRNSCancelation of shares
24th May 20182:24 pmRNSFinal Terms
11th May 20187:00 amRNSAcquisition
26th Apr 20184:52 pmRNS1st Quarter Results
17th Apr 20184:58 pmRNSFinal Terms
13th Apr 20187:16 amRNSAcquisition
11th Apr 20185:08 pmRNSAcquisition
28th Mar 20185:02 pmRNSCapex
22nd Mar 20183:14 pmRNSIssue of Debt
19th Mar 20189:04 amRNSAcquisition
13th Mar 20184:57 pmRNSIssue of Debt
2nd Mar 20187:00 amRNSProspectus Supplement
1st Mar 20184:53 pmRNSAcquisition
22nd Feb 20185:04 pmRNS2017 Results
25th Jan 20184:52 pmRNSNew capacity
11th Jan 20185:12 pmRNSAcquisition
20th Dec 20174:50 pmRNSIssue of Debt
19th Dec 20177:27 amRNSAcquisition
6th Dec 20174:49 pmRNSAcquisition
4th Dec 20177:04 amRNSAcquisition
30th Nov 20174:55 pmRNSShares cancellation
24th Nov 20174:51 pmRNSAcquisition
23rd Nov 20176:12 pmRNSDecisions of Board of Directors
26th Oct 20176:08 pmRNSNine-months sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.